Prospective Collection of Female and Male Specimens for PANTHER® System Testing
Status: | Completed |
---|---|
Conditions: | Infectious Disease |
Therapuetic Areas: | Immunology / Infectious Diseases |
Healthy: | No |
Age Range: | 16 - Any |
Updated: | 10/19/2013 |
Start Date: | February 2012 |
End Date: | August 2013 |
Contact: | Steve Thomas, BS |
Email: | Stephen.Thomas@gen-probe.com |
Phone: | 858-731-5830 |
Prospective Collection of Female First-catch Urine, Vaginal Swab, Cervical, and Endocervical Swab Specimens and Male Urethral Swab and First-catch Urine Specimens for Testing With the PANTHER® System
The objective of this study is to obtain female first-catch urine, vaginal, cervical and
endocervical swabs and male first-catch urine and urethral swabs for testing with multiple
APTIMA Assays on the Gen-Probe PANTHER® System
Inclusion Criteria:
- The subject is at least 16 years of age at the time of enrollment and is currently
sexually active (has had intercourse within the past 12 months)
- The subject and/or legally authorized representative is willing to undergo the
informed consent process prior to study participation (a minor will need the
documented consent of his/her parent or legal guardian, unless the site has an
institutional review board (IRB)-approved waiver for parental consent for minors)
In addition, the subject must meet at least one of the following criteria:
- The subject reports symptoms consistent with a suspected STI such as abnormal
discharge, genital itching, pain/discomfort during sexual intercourse or urination,
and/or lower abdominal discomfort
- Subject is asymptomatic and known to be partners with, or a contact of, a person with
a confirmed or suspected STI(s)
- Subject is asymptomatic and undergoing screening evaluation for possible STIs
- Subject (female) is asymptomatic and undergoing a routine examination with a pelvic
examination
Exclusion Criteria:
- A potential subject will be ineligible for clinical trial enrollment if the subject,
clinician, or medical record reports any of the following:
- The subject took antibiotic medications within the last 21 days
- Subject already participated in this study
- Subject has a history of illness that the principal investigator (PI) or designee
considers could interfere with or affect the conduct, results, and/or completion of
the clinical trial
- Subject has a history of illness that the PI or designee considers could create an
unacceptable risk to the subject if enrolled
We found this trial at
13
sites
3333 Burnet Avenue # Mlc3008
Cincinnati, Ohio 45229
Cincinnati, Ohio 45229
1-513-636-4200
Cincinnati Children's Hospital Medical Center Patients and families from across the region and around the...
Click here to add this to my saved trials
University of Alabama at Birmingham The University of Alabama at Birmingham (UAB) traces its roots...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials